Cargando…
Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma
BACKGROUND: Von Hippel-Lindau (VHL) disease is a multi-systemic hereditary disease associated with several benign and malignant tumor entities, including clear cell renal cell carcinoma (ccRCC). Since ccRCCs grow slowly, nephron sparing surgery is typically performed at a tumor diameter of 3–4 cm be...
Autores principales: | Schuhmacher, Patrick, Kim, Emily, Hahn, Felix, Sekula, Peggy, Jilg, Cordula Annette, Leiber, Christian, Neumann, Hartmut P., Schultze-Seemann, Wolfgang, Walz, Gerd, Zschiedrich, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819544/ https://www.ncbi.nlm.nih.gov/pubmed/31661010 http://dx.doi.org/10.1186/s13023-019-1206-2 |
Ejemplares similares
-
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
por: Kirste, Simon, et al.
Publicado: (2022) -
Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment
por: Klingler, Jan-Helge, et al.
Publicado: (2020) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005) -
Renal Cell Carcinoma in von Hippel–Lindau Disease—From Tumor Genetics to Novel Therapeutic Strategies
por: Kim, Emily, et al.
Publicado: (2018) -
Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020)